Scholars Central

Research articlePublished 12 Oct 2015

USE OF AUTOLOGOUS ADIPOSE TISSUE DERIVED STROMAL VASCULAR FRACTION IN TREATMENT OF KNEE OSTEOARTHRITIS AND CHONDRAL LESIONS

Authors: Vinay Tantuway, S. A. Mustafa Johar, Murtza Rassiwala, Chhavi Jain (MPT), Neethu Shaji5 Farida Bandookwala

Journal of Evidence-Based Medicine and Healthcare

Volume 2 · Issue 10 · Pages 1–14

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Osteoarthritis is a joint inflammation that results from cartilage degeneration. It can be caused by aging, heredity and injury from trauma or disease. Stromal vascular fraction (SVF), containing large amount of stem cells and other regenerative cells, can be easily obtained from loose connective tissue that is associated with adipose tissue. Here we evaluated safety and clinical efficacy of freshly isolated autologous SVF cells in patients with grade 2-4 degenerative osteoarthritis (OA). A total of 31 patients underwent standard liposuction under local anesthesia and SVF cells were isolated and prepared for application into joints. A total of 61 joints, mainly knee and hip joints, were treated with a single dose of SVF cells. 19 patients were followed for minimum 6 weeks for safety and efficacy. Modified KOOS Clinical Score was used to evaluate clinical effect and was based on pain, non-steroid analgesic usage, limping, extent of joint movement, and stiffness evaluation before and at pre-operative, 1 week post-op, 1 month and 6 weeks after the treatment. No serious side effects, systemic infection or cancer was associated with SVF cell therapy. All patients improved after the treatment. Average KOOS score improved from pre-operative 37.5 to post-operative 6 week average 66.6. All sub scale parameter for pain, symptoms, activity of living & quality of life are also improved. Higher grade of OA were associated with slower healing. In conclusion, here we report a novel and promising treatment approach for patients with degenerative OA that is safe, cost-effective, and relying only on autologous cells, and can be used as one of the minimal invasive treatment modality for osteoarthritisTotal joint arthroplasty (

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Evidence-Based Medicine and Healthcare.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Vinay Tantuway”
  • BylineArticles whose byline prints “S. A. Mustafa Johar”
  • BylineArticles whose byline prints “Murtza Rassiwala”
  • BylineArticles whose byline prints “Chhavi Jain (MPT)”
  • BylineArticles whose byline prints “Neethu Shaji5 Farida Bandookwala”